+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Sentinel Lymph Node Biopsy Imaging Agents Market Size, Share & Trends Analysis Report by Product, Application, Procedure, End Use, Region, and Growth Forecasts, 2026-2033

  • PDF Icon

    Report

  • 110 Pages
  • April 2026
  • Region: Global
  • Grand View Research
  • ID: 6241224
The global sentinel lymph node biopsy imaging agents market size was estimated at USD 101.48 million in 2025 and is projected to reach USD 184.10 million by 2033, growing at a CAGR of 7.96% from 2026 to 2033, primarily driven by the rising global burden of cancer, particularly breast cancer and melanoma, which increases the need for accurate staging and lymphatic mapping techniques. As healthcare systems increasingly shift toward minimally invasive diagnostic procedures, sentinel lymph node biopsy imaging agents (SLNB) is preferred over full lymph node dissection due to reduced complications and faster recovery, thereby boosting demand for imaging agents.

Moreover, technological advancements in radiotracers, fluorescent dyes, and hybrid imaging agents are significantly improving detection accuracy and surgical outcomes, encouraging wider adoption. Growing clinical research activities, regulatory approvals, and funding in oncology, along with increasing awareness of early cancer detection, further accelerate market expansion.

Technological advancements in tracers, including fluorescent agents, hybrid tracers, and targeted imaging compounds, are significantly improving the accuracy and real-time visualization of sentinel lymph nodes. These innovations improve detection rates and reduce reliance on traditional methods, driving greater adoption in minimally invasive and image-guided surgeries. As a result, advanced tracers are becoming a key factor in improving surgical precision and expanding the market for SLNB imaging agents.

The rising global cancer incidence, particularly breast cancer and melanoma, is a major driver of the market, as these procedures are essential for accurate cancer staging and treatment planning. The growing patient population increases the demand for precise lymphatic mapping, thereby supporting the adoption of advanced imaging agents to improve diagnostic accuracy and surgical outcomes.

The growing preference for minimally invasive procedures is driving the adoption of sentinel lymph node biopsy as an effective alternative to extensive lymph node dissection. This shift is increasing demand for imaging agents that enable accurate lymphatic mapping while minimizing surgical complications and shortening recovery time. As clinicians increasingly focus on improving patient outcomes and procedural efficiency, the use of precise and user-friendly SLNB imaging agents continues to expand. For instance, in September 2025, King George’s Medical University (KGMU) in Lucknow, India, performed an advanced minimally invasive gynecologic cancer surgery using an ICG-enabled laparoscopic immunofluorescence system, allowing real-time lymph node assessment. This approach enhances intraoperative visualization and delivers benefits to patients, including smaller incisions, reduced pain, faster recovery, and improved safety.

Global Sentinel Lymph Node Biopsy Imaging Agents Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis on the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the global sentinel lymph node biopsy imaging agents market report based on product, application, procedure, end use, and region:

Product Outlook (Revenue, USD Million, 2021-2033)

  • Radioactive Tracers
  • Technetium-99m Sulfur Colloid
  • Technetium-99m Nanocolloid
  • Tilmanocept (Lymphoseek)
  • Others
  • Dye-Based Agents
  • Isosulfan Blue
  • Patent Blue V
  • Methylene Blue
  • Fluorescent Imaging Agents
  • Others

Application Outlook (Revenue, USD Million, 2021-2033)

  • Breast Cancer
  • Melanoma
  • Head & Neck Cancer
  • Gynecological Cancers
  • Other Indications

Procedure Outlook (Revenue, USD Million, 2021-2033)

  • Open Surgery
  • Minimally Invasive Surgery

End Use Outlook (Revenue, USD Million, 2021-2033)

  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Cancer Specialty Clinics

Regional Outlook (Revenue, USD Million, 2021-2033)

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Thailand
  • Latin America
  • Brazil
  • Argentina
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Application
1.1.3. Procedure
1.1.4. End Use
1.1.5. Regional scope
1.1.6. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.2. Volume price analysis (Model 2)
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Sentinel Lymph Node Biopsy Imaging Agents Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.2.3. Market opportunity analysis
3.2.4. Market challenge analysis
3.3. Sentinel Lymph Node Biopsy Imaging Agents Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis
Chapter 4. Sentinel Lymph Node Biopsy Imaging Agents Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global Sentinel Lymph Node Biopsy Imaging Agents Market Product Movement Analysis
4.3. Global Sentinel Lymph Node Biopsy Imaging Agents Market Size & Trend Analysis, by Product 2021 to 2033 (USD Million)
4.4. Radioactive Tracers
4.4.1. Radioactive tracers market estimates and forecasts for 2021 to 2033 (USD Million)
4.5. Dye-Based Agents
4.5.1. Dye-based agents market estimates and forecasts for 2021 to 2033 (USD Million)
Chapter 5. Sentinel Lymph Node Biopsy Imaging Agents Market: Application Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global Sentinel Lymph Node Biopsy Imaging Agents Market Application Movement Analysis
5.3. Global Sentinel Lymph Node Biopsy Imaging Agents Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
5.4. Breast Cancer
5.4.1. Breast cancer market estimates and forecast 2021 to 2033 (USD Million)
5.5. Melanoma
5.5.1. Melanoma market estimates and forecast 2021 to 2033 (USD Million)
5.6. Head & Neck Cancer
5.6.1. Head & neck cancer market estimates and forecast 2021 to 2033 (USD Million)
5.7. Gynecological Cancers
5.7.1. Gynecological cancers market estimates and forecast 2021 to 2033 (USD Million)
5.8. Other Indications
5.8.1. Other indications market estimates and forecasts for 2021 to 2033 (USD Million)
Chapter 6. Sentinel Lymph Node Biopsy Imaging Agents Market: Procedure Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Global Sentinel Lymph Node Biopsy Imaging Agents Market Procedure Movement Analysis
6.3. Global Sentinel Lymph Node Biopsy Imaging Agents Market Size & Trend Analysis, by Procedure, 2021 to 2033 (USD Million)
6.4. Open Surgery
6.4.1. Open surgery market estimates and forecast 2021 to 2033 (USD Million)
6.5. Minimally Invasive Surgery
6.5.1. Minimally invasive surgery market estimates and forecast 2021 to 2033 (USD Million)
Chapter 7. Sentinel Lymph Node Biopsy Imaging Agents Market: End Use Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Global Sentinel Lymph Node Biopsy Imaging Agents Market End Use Movement Analysis
7.3. Global Sentinel Lymph Node Biopsy Imaging Agents Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
7.4. Hospitals
7.4.1. Hospitals market estimates and forecast 2021 to 2033 (USD Million)
7.5. Sinus Lift
7.5.1. Sinus lift market estimates and forecast 2021 to 2033 (USD Million)
7.6. Ambulatory Surgical Centers
7.6.1. Ambulatory surgical centers market estimates and forecast 2021 to 2033 (USD Million)
7.7. Cancer Specialty Clinics
7.7.1. Cancer specialty clinics market estimates and forecast 2021 to 2033 (USD Million)
Chapter 8. Sentinel Lymph Node Biopsy Imaging Agents Market: Regional Estimates & Trend Analysis by Product, by Procedure, by End Use and by Application
8.1. Regional Dashboard
8.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
8.3. North America
8.3.1. Market estimates and forecast, 2021-2033 (Revenue, USD Million)
8.3.2. U.S.
8.3.3. Canada
8.3.4. Mexico
8.4. Europe
8.4.1. UK
8.4.2. Germany
8.4.3. France
8.4.4. Italy
8.4.5. Spain
8.4.6. Denmark
8.4.7. Sweden
8.4.8. Norway
8.5. Asia-Pacific
8.5.1. Japan
8.5.2. India
8.5.3. China
8.5.4. South Korea
8.5.5. Australia
8.5.6. Thailand
8.6. Latin America
8.6.1. Brazil
8.6.2. Argentina
8.7. MEA
8.7.1. South Africa
8.7.2. Saudi Arabia
8.7.3. UAE
8.7.4. Kuwait
Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis, by Key Market Participants
9.2. Company/Competition Categorization
9.2.1. Innovators
9.3. Vendor Landscape
9.3.1. List of key distributors and channel partners
9.3.2. Key customers
9.3.3. Global Key company market share analysis, 2025
9.3.4. Cardinal Health
9.3.5. Curium Pharma
9.3.6. Jubilant Pharmova
9.3.7. Guerbet
9.3.8. Diagnostic Green
9.3.9. Sun Pharmaceutical Industries, Inc.
9.3.10. GE HealthCare
9.3.11. VIATRIS (Mylan Inc.)
9.3.12. Macsen Labs
9.3.13. POLATOM
9.3.14. Hologic Inc.
9.4. Heat Map Analysis/ Company Market Position Analysis
9.5. Estimated Company Market Share Analysis, 2025
9.6. List of Other Key Market Players
List of Tables
Table 1. List of secondary sources
Table 2. List of abbreviation
Table 3. North America sentinel lymph node biopsy imaging agents market, by country, 2021-2033 (USD Million)
Table 4. North America sentinel lymph node biopsy imaging agents market, by product, 2021-2033 (USD Million)
Table 5. North America sentinel lymph node biopsy imaging agents market, by application, 2021-2033 (USD Million)
Table 6. North America sentinel lymph node biopsy imaging agents market, by procedure, 2021-2033 (USD Million)
Table 7. North America sentinel lymph node biopsy imaging agents market, by end use, 2021-2033 (USD Million)
Table 8. U.S. sentinel lymph node biopsy imaging agents market, by product, 2021-2033 (USD Million)
Table 9. U.S. sentinel lymph node biopsy imaging agents market, by application, 2021-2033 (USD Million)
Table 10. U.S. sentinel lymph node biopsy imaging agents market, by procedure, 2021-2033 (USD Million)
Table 11. U.S. sentinel lymph node biopsy imaging agents market, by end use, 2021-2033 (USD Million)
Table 12. Canada sentinel lymph node biopsy imaging agents market, by product, 2021-2033 (USD Million)
Table 13. Canada sentinel lymph node biopsy imaging agents market, by application, 2021-2033 (USD Million)
Table 14. Canada sentinel lymph node biopsy imaging agents market, by procedure, 2021-2033 (USD Million)
Table 15. Canada sentinel lymph node biopsy imaging agents market, by end use, 2021-2033 (USD Million)
Table 16. Mexico sentinel lymph node biopsy imaging agents market, by product, 2021-2033 (USD Million)
Table 17. Mexico sentinel lymph node biopsy imaging agents market, by application, 2021-2033 (USD Million)
Table 18. Mexico sentinel lymph node biopsy imaging agents market, by procedure, 2021-2033 (USD Million)
Table 19. Mexico sentinel lymph node biopsy imaging agents market, by end use, 2021-2033 (USD Million)
Table 20. Europe sentinel lymph node biopsy imaging agents market, by country, 2021-2033 (USD Million)
Table 21. Europe sentinel lymph node biopsy imaging agents market, by product, 2021-2033 (USD Million)
Table 22. Europe sentinel lymph node biopsy imaging agents market, by application, 2021-2033 (USD Million)
Table 23. Europe sentinel lymph node biopsy imaging agents market, by procedure, 2021-2033 (USD Million)
Table 24. Europe sentinel lymph node biopsy imaging agents market, by end use, 2021-2033 (USD Million)
Table 25. UK sentinel lymph node biopsy imaging agents market, by product, 2021-2033 (USD Million)
Table 26. UK sentinel lymph node biopsy imaging agents market, by application, 2021-2033 (USD Million)
Table 27. UK sentinel lymph node biopsy imaging agents market, by procedure, 2021-2033 (USD Million)
Table 28. UK sentinel lymph node biopsy imaging agents market, by end use, 2021-2033 (USD Million)
Table 29. Germany sentinel lymph node biopsy imaging agents market, by product, 2021-2033 (USD Million)
Table 30. Germany sentinel lymph node biopsy imaging agents market, by application, 2021-2033 (USD Million)
Table 31. Germany sentinel lymph node biopsy imaging agents market, by procedure, 2021-2033 (USD Million)
Table 32. Germany sentinel lymph node biopsy imaging agents market, by end use, 2021-2033 (USD Million)
Table 33. France sentinel lymph node biopsy imaging agents market, by product, 2021-2033 (USD Million)
Table 34. France sentinel lymph node biopsy imaging agents market, by application, 2021-2033 (USD Million)
Table 35. France sentinel lymph node biopsy imaging agents market, by procedure, 2021-2033 (USD Million)
Table 36. France sentinel lymph node biopsy imaging agents market, by end use, 2021-2033 (USD Million)
Table 37. Italy sentinel lymph node biopsy imaging agents market, by product, 2021-2033 (USD Million)
Table 38. Italy sentinel lymph node biopsy imaging agents market, by application, 2021-2033 (USD Million)
Table 39. Italy sentinel lymph node biopsy imaging agents market, by procedure, 2021-2033 (USD Million)
Table 40. Italy sentinel lymph node biopsy imaging agents market, by end use, 2021-2033 (USD Million)
Table 41. Spain sentinel lymph node biopsy imaging agents market, by product, 2021-2033 (USD Million)
Table 42. Spain sentinel lymph node biopsy imaging agents market, by application, 2021-2033 (USD Million)
Table 43. Spain sentinel lymph node biopsy imaging agents market, by procedure, 2021-2033 (USD Million)
Table 44. Spain sentinel lymph node biopsy imaging agents market, by end use, 2021-2033 (USD Million)
Table 45. Denmark sentinel lymph node biopsy imaging agents market, by product, 2021-2033 (USD Million)
Table 46. Denmark sentinel lymph node biopsy imaging agents market, by application, 2021-2033 (USD Million)
Table 47. Denmark sentinel lymph node biopsy imaging agents market, by procedure, 2021-2033 (USD Million)
Table 48. Denmark sentinel lymph node biopsy imaging agents market, by end use, 2021-2033 (USD Million)
Table 49. Sweden sentinel lymph node biopsy imaging agents market, by product, 2021-2033 (USD Million)
Table 50. Sweden sentinel lymph node biopsy imaging agents market, by application, 2021-2033 (USD Million)
Table 51. Sweden sentinel lymph node biopsy imaging agents market, by procedure, 2021-2033 (USD Million)
Table 52. Sweden sentinel lymph node biopsy imaging agents market, by end use, 2021-2033 (USD Million)
Table 53. Norway sentinel lymph node biopsy imaging agents market, by product, 2021-2033 (USD Million)
Table 54. Norway sentinel lymph node biopsy imaging agents market, by application, 2021-2033 (USD Million)
Table 55. Norway sentinel lymph node biopsy imaging agents market, by procedure, 2021-2033 (USD Million)
Table 56. Norway sentinel lymph node biopsy imaging agents market, by end use, 2021-2033 (USD Million)
Table 57. Asia-Pacific sentinel lymph node biopsy imaging agents market, by country, 2021-2033 (USD Million)
Table 58. Asia-Pacific sentinel lymph node biopsy imaging agents market, by product, 2021-2033 (USD Million)
Table 59. Asia-Pacific sentinel lymph node biopsy imaging agents market, by application, 2021-2033 (USD Million)
Table 60. Asia-Pacific sentinel lymph node biopsy imaging agents market, by procedure, 2021-2033 (USD Million)
Table 61. Asia-Pacific sentinel lymph node biopsy imaging agents market, by end use, 2021-2033 (USD Million)
Table 62. China sentinel lymph node biopsy imaging agents market, by product, 2021-2033 (USD Million)
Table 63. China sentinel lymph node biopsy imaging agents market, by application, 2021-2033 (USD Million)
Table 64. China sentinel lymph node biopsy imaging agents market, by procedure, 2021-2033 (USD Million)
Table 65. China sentinel lymph node biopsy imaging agents market, by end use, 2021-2033 (USD Million)
Table 66. Japan sentinel lymph node biopsy imaging agents market, by product, 2021-2033 (USD Million)
Table 67. Japan sentinel lymph node biopsy imaging agents market, by application, 2021-2033 (USD Million)
Table 68. Japan sentinel lymph node biopsy imaging agents market, by procedure, 2021-2033 (USD Million)
Table 69. Japan sentinel lymph node biopsy imaging agents market, by end use, 2021-2033 (USD Million)
Table 70. India sentinel lymph node biopsy imaging agents market, by product, 2021-2033 (USD Million)
Table 71. India sentinel lymph node biopsy imaging agents market, by application, 2021-2033 (USD Million)
Table 72. India sentinel lymph node biopsy imaging agents market, by procedure, 2021-2033 (USD Million)
Table 73. India sentinel lymph node biopsy imaging agents market, by end use, 2021-2033 (USD Million)
Table 74. South Korea sentinel lymph node biopsy imaging agents market, by product, 2021-2033 (USD Million)
Table 75. South Korea sentinel lymph node biopsy imaging agents market, by application, 2021-2033 (USD Million)
Table 76. South Korea sentinel lymph node biopsy imaging agents market, by procedure, 2021-2033 (USD Million)
Table 77. South Korea sentinel lymph node biopsy imaging agents market, by end use, 2021-2033 (USD Million)
Table 78. Australia sentinel lymph node biopsy imaging agents market, by product, 2021-2033 (USD Million)
Table 79. Australia sentinel lymph node biopsy imaging agents market, by application, 2021-2033 (USD Million)
Table 80. Australia sentinel lymph node biopsy imaging agents market, by procedure, 2021-2033 (USD Million)
Table 81. Australia sentinel lymph node biopsy imaging agents market, by end use, 2021-2033 (USD Million)
Table 82. Thailand sentinel lymph node biopsy imaging agents market, by product, 2021-2033 (USD Million)
Table 83. Thailand sentinel lymph node biopsy imaging agents market, by application, 2021-2033 (USD Million)
Table 84. Thailand sentinel lymph node biopsy imaging agents market, by procedure, 2021-2033 (USD Million)
Table 85. Thailand sentinel lymph node biopsy imaging agents market, by end use, 2021-2033 (USD Million)
Table 86. Latin America sentinel lymph node biopsy imaging agents market, by country, 2021-2033 (USD Million)
Table 87. Latin America sentinel lymph node biopsy imaging agents market, by product, 2021-2033 (USD Million)
Table 88. Latin America sentinel lymph node biopsy imaging agents market, by application, 2021-2033 (USD Million)
Table 89. Latin America sentinel lymph node biopsy imaging agents market, by procedure, 2021-2033 (USD Million)
Table 90. Latin America sentinel lymph node biopsy imaging agents market, by end use, 2021-2033 (USD Million)
Table 91. Brazil sentinel lymph node biopsy imaging agents market, by product, 2021-2033 (USD Million)
Table 92. Brazil sentinel lymph node biopsy imaging agents market, by application, 2021-2033 (USD Million)
Table 93. Brazil sentinel lymph node biopsy imaging agents market, by procedure, 2021-2033 (USD Million)
Table 94. Brazil sentinel lymph node biopsy imaging agents market, by end use, 2021-2033 (USD Million)
Table 95. Argentina sentinel lymph node biopsy imaging agents market, by product, 2021-2033 (USD Million)
Table 96. Argentina sentinel lymph node biopsy imaging agents market, by application, 2021-2033 (USD Million)
Table 97. Argentina sentinel lymph node biopsy imaging agents market, by procedure, 2021-2033 (USD Million)
Table 98. Argentina sentinel lymph node biopsy imaging agents market, by end use, 2021-2033 (USD Million)
Table 99. Middle East & Africa sentinel lymph node biopsy imaging agents market, by country, 2021-2033 (USD Million)
Table 100. Middle East & Africa sentinel lymph node biopsy imaging agents market, by product, 2021-2033 (USD Million)
Table 101. Middle East & Africa sentinel lymph node biopsy imaging agents market, by application, 2021-2033 (USD Million)
Table 102. Middle East & Africa sentinel lymph node biopsy imaging agents market, by procedure, 2021-2033 (USD Million)
Table 103. Middle East & Africa sentinel lymph node biopsy imaging agents market, by end use, 2021-2033 (USD Million)
Table 104. South Africa sentinel lymph node biopsy imaging agents market, by product, 2021-2033 (USD Million)
Table 105. South Africa sentinel lymph node biopsy imaging agents market, by application, 2021-2033 (USD Million)
Table 106. South Africa sentinel lymph node biopsy imaging agents market, by procedure, 2021-2033 (USD Million)
Table 107. South Africa sentinel lymph node biopsy imaging agents market, by end use, 2021-2033 (USD Million)
Table 108. Saudi Arabia sentinel lymph node biopsy imaging agents market, by product, 2021-2033 (USD Million)
Table 109. Saudi Arabia sentinel lymph node biopsy imaging agents market, by application, 2021-2033 (USD Million)
Table 110. Saudi Arabia sentinel lymph node biopsy imaging agents market, by procedure, 2021-2033 (USD Million)
Table 111. Saudi Arabia sentinel lymph node biopsy imaging agents market, by end use, 2021-2033 (USD Million)
Table 112. UAE sentinel lymph node biopsy imaging agents market, by product, 2021-2033 (USD Million)
Table 113. UAE sentinel lymph node biopsy imaging agents market, by application, 2021-2033 (USD Million)
Table 114. UAE sentinel lymph node biopsy imaging agents market, by procedure, 2021-2033 (USD Million)
Table 115. UAE sentinel lymph node biopsy imaging agents market, by end use, 2021-2033 (USD Million)
Table 116. Kuwait sentinel lymph node biopsy imaging agents market, by product, 2021-2033 (USD Million)
Table 117. Kuwait sentinel lymph node biopsy imaging agents market, by application, 2021-2033 (USD Million)
Table 118. Kuwait sentinel lymph node biopsy imaging agents market, by procedure, 2021-2033 (USD Million)
Table 119. Kuwait sentinel lymph node biopsy imaging agents market, by end use, 2021-2033 (USD Million)
List of Figures
Figure 1 Information Procurement
Figure 2 Primary Research Pattern
Figure 3 Market Research Approaches
Figure 4 Value Chain-Based Sizing & Forecasting
Figure 5 Market Formulation & Validation
Figure 6 Sentinel Lymph Node Biopsy Imaging Agents Market, Market Segmentation
Figure 7 Market Driver Analysis (Current & Future Impact)
Figure 8 Market Restraint Analysis (Current & Future Impact)
Figure 9 Market Opportunity Analysis (Current & Future Impact)
Figure 10 Market Challenge Analysis (Current & Future Impact)
Figure 11 SWOT Analysis, by Factor (Political & Legal, Economic, and Technological)
Figure 12 Porter’s Five Forces Analysis
Figure 13 Regional Marketplace: Key Takeaways
Figure 14 Sentinel Lymph Node Biopsy Imaging Agents Market: Product movement analysis
Figure 15 Radioactive Tracers Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 16 Technetium-99m Sulfur Colloid Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 17 Technetium-99m Nanocolloid Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 18 Tilmanocept (Lymphoseek) Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 19 Others Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 20 Isosulfan Blue Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 21 Patent Blue V Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 22 Methylene Blue Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 23 Fluorescent Imaging Agents Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 24 Others Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 25 Sentinel Lymph Node Biopsy Imaging Agents Market: Application Movement Analysis
Figure 26 Breast Cancer Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 27 Melanoma Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 28 Head & Neck Cancer Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 29 Gynecological Cancers Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 30 Other Indications Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 31 Sentinel Lymph Node Biopsy Imaging Agents Market: Procedure Movement Analysis
Figure 32 Open Surgery Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 33 Minimally Invasive Surgery Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 34 Sentinel Lymph Node Biopsy Imaging Agents Market: Application Movement Analysis
Figure 35 Hospitals Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 36 Ambulatory Surgical Centers (ASCs) Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 37 Cancer Specialty Clinics Market Estimates and Forecast, 2021-2033 (USD Million)
Figure 38 Regional Outlook, 2025 & 2033
Figure 39 North America Sentinel Lymph Node Biopsy Imaging Agents Market, 2021-2033 (USD Million)
Figure 40 U.S. Sentinel Lymph Node Biopsy Imaging Agents Market, 2021-2033 (USD Million)
Figure 41 Canada Sentinel Lymph Node Biopsy Imaging Agents Market, 2021-2033 (USD Million)
Figure 42 Mexico Sentinel Lymph Node Biopsy Imaging Agents Market, 2021-2033 (USD Million)
Figure 43 Europe Sentinel Lymph Node Biopsy Imaging Agents Market, 2021-2033 (USD Million)
Figure 44 Germany Sentinel Lymph Node Biopsy Imaging Agents Market, 2021-2033 (USD Million)
Figure 45 UK Sentinel Lymph Node Biopsy Imaging Agents Market, 2021-2033 (USD Million)
Figure 46 France Sentinel Lymph Node Biopsy Imaging Agents Market, 2021-2033 (USD Million)
Figure 47 Italy Sentinel Lymph Node Biopsy Imaging Agents Market, 2021-2033 (USD Million)
Figure 48 Spain Sentinel Lymph Node Biopsy Imaging Agents Market, 2021-2033 (USD Million)
Figure 49 Denmark Sentinel Lymph Node Biopsy Imaging Agents Market, 2021-2033 (USD Million)
Figure 50 Sweden Sentinel Lymph Node Biopsy Imaging Agents Market, 2021-2033 (USD Million)
Figure 51 Norway Sentinel Lymph Node Biopsy Imaging Agents Market, 2021-2033 (USD Million)
Figure 52 Asia-Pacific Sentinel Lymph Node Biopsy Imaging Agents Market, 2021-2033 (USD Million)
Figure 53 Japan Sentinel Lymph Node Biopsy Imaging Agents Market, 2021-2033 (USD Million)
Figure 54 China Sentinel Lymph Node Biopsy Imaging Agents Market, 2021-2033 (USD Million)
Figure 55 India Sentinel Lymph Node Biopsy Imaging Agents Market, 2021-2033 (USD Million)
Figure 56 Australia Sentinel Lymph Node Biopsy Imaging Agents Market, 2021-2033 (USD Million)
Figure 57 South Korea Sentinel Lymph Node Biopsy Imaging Agents Market, 2021-2033 (USD Million)
Figure 58 Thailand Sentinel Lymph Node Biopsy Imaging Agents Market, 2021-2033 (USD Million)
Figure 59 Latin America Sentinel Lymph Node Biopsy Imaging Agents Market, 2021-2033 (USD Million)
Figure 60 Brazil Sentinel Lymph Node Biopsy Imaging Agents Market, 2021-2033 (USD Million)
Figure 61 Argentina Sentinel Lymph Node Biopsy Imaging Agents Market, 2021-2033 (USD Million)
Figure 62 Middle East and Africa Sentinel Lymph Node Biopsy Imaging Agents Market, 2021-2033 (USD Million)
Figure 63 South Africa Sentinel Lymph Node Biopsy Imaging Agents Market, 2021-2033 (USD Million)
Figure 64 Saudi Arabia Sentinel Lymph Node Biopsy Imaging Agents Market, 2021-2033 (USD Million)
Figure 65 UAE Sentinel Lymph Node Biopsy Imaging Agents Market, 2021-2033 (USD Million)
Figure 66 Kuwait Sentinel Lymph Node Biopsy Imaging Agents Market, 2021-2033 (USD Million)

Companies Mentioned

  • Cardinal Health
  • Curium Pharma
  • Jubilant Pharmova
  • Guerbet
  • Diagnostic Green
  • Sun Pharmaceutical Industries, Inc.
  • GE HealthCare
  • VIATRIS (Mylan Inc.)
  • Macsen Labs
  • POLATOM
  • Hologic Inc.

Table Information